{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:24:51Z","timestamp":1777530291400,"version":"3.51.4"},"reference-count":102,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1378\/chest.14-1925","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T11:27:13Z","timestamp":1427455633000},"page":"550-558","source":"Crossref","is-referenced-by-count":20,"title":["Hepatorenal Disorders"],"prefix":"10.1016","volume":"148","author":[{"given":"Ali","family":"Al-Khafaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitra K.","family":"Nadim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1378\/chest.14-1925_bib1","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"issue":"5","key":"10.1378\/chest.14-1925_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"issue":"1","key":"10.1378\/chest.14-1925_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"issue":"4","key":"10.1378\/chest.14-1925_bib4","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"issue":"11","key":"10.1378\/chest.14-1925_bib5","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1378\/chest.14-1925_bib6","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"suppl","key":"10.1378\/chest.14-1925_bib7","first-page":"1","article-title":"KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group","year":"2012","journal-title":"Kidney Inter"},{"issue":"11","key":"10.1378\/chest.14-1925_bib8","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00134-007-0760-6","article-title":"RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients","volume":"33","author":"Jenq","year":"2007","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1378\/chest.14-1925_bib9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1440-1746.2009.05908.x","article-title":"RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit","volume":"24","author":"Cholongitas","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1378\/chest.14-1925_bib10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00134-005-2842-7","article-title":"The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis","volume":"31","author":"du Cheyron","year":"2005","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1378\/chest.14-1925_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatol"},{"issue":"3","key":"10.1378\/chest.14-1925_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J Hepatol"},{"issue":"5","key":"10.1378\/chest.14-1925_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201211-1983OC","article-title":"Mechanisms of cardiac and renal dysfunction in patients dying of sepsis","volume":"187","author":"Takasu","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1378\/chest.14-1925_bib14","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1378\/chest.14-1925_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s","year":"1993","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1378\/chest.14-1925_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1378\/chest.14-1925_bib17","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/j.1600-6143.2008.02426.x","article-title":"Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy","volume":"8","author":"Wadei","year":"2008","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1378\/chest.14-1925_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"issue":"2","key":"10.1378\/chest.14-1925_bib19","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.1840200215","article-title":"Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease","volume":"20","author":"Platt","year":"1994","journal-title":"Hepatology"},{"issue":"5","key":"10.1378\/chest.14-1925_bib20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"issue":"5","key":"10.1378\/chest.14-1925_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"issue":"3","key":"10.1378\/chest.14-1925_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MAJ.0000000000000268","article-title":"New insight into volume overload and hepatorenal syndrome in cirrhosis, \u201cthe hepatorenal reflex hypothesis.\u201d","volume":"348","author":"Rzouq","year":"2014","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1378\/chest.14-1925_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1378\/chest.14-1925_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/gast.2002.30305","article-title":"Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.","volume":"122","author":"Ros","year":"2002","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1378\/chest.14-1925_bib25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI7458","article-title":"Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility","volume":"104","author":"Wiest","year":"1999","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1378\/chest.14-1925_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.20632","article-title":"Bacterial translocation (BT) in cirrhosis","volume":"41","author":"Wiest","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1378\/chest.14-1925_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/liv.12021","article-title":"Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications","volume":"33","author":"Bellot","year":"2013","journal-title":"Liver Int"},{"issue":"3","key":"10.1378\/chest.14-1925_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-139-3-200308050-00008","article-title":"The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial","volume":"139","author":"Rasaratnam","year":"2003","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1378\/chest.14-1925_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","article-title":"Assessing renal function in cirrhotic patients: problems and pitfalls","volume":"41","author":"Sherman","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1378\/chest.14-1925_bib30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1053\/jlts.2000.9736","article-title":"Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease","volume":"6","author":"Figueiredo","year":"2000","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1378\/chest.14-1925_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/gut.50.1.106","article-title":"Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver","volume":"50","author":"Gerbes","year":"2002","journal-title":"Gut"},{"issue":"6 pt 1","key":"10.1378\/chest.14-1925_bib32","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/clinchem\/48.6.850","article-title":"Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis","volume":"48","author":"Orlando","year":"2002","journal-title":"Clin Chem"},{"issue":"10","key":"10.1378\/chest.14-1925_bib33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1478-3231.2009.02105.x","article-title":"Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels","volume":"29","author":"Seo","year":"2009","journal-title":"Liver Int"},{"issue":"1","key":"10.1378\/chest.14-1925_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","article-title":"Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.","volume":"36","author":"Coll","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1378\/chest.14-1925_bib35","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/ncpneph0765","article-title":"Cystatin C has prognostic value after liver transplantation","volume":"4","author":"Kniepeiss","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"issue":"1","key":"10.1378\/chest.14-1925_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2215\/CJN.03400410","article-title":"Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis","volume":"6","author":"Xirouchakis","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1378\/chest.14-1925_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"6","key":"10.1378\/chest.14-1925_bib38","first-page":"342","article-title":"Glomerular filtration rate measurement in cirrhotic patients with renal failure","volume":"50","author":"Roy","year":"1998","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1378\/chest.14-1925_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1378\/chest.14-1925_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1378\/chest.14-1925_bib41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lt.20017","article-title":"Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations","volume":"10","author":"Gonwa","year":"2004","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1378\/chest.14-1925_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1155\/2006\/858053","article-title":"Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better?","volume":"20","author":"MacAulay","year":"2006","journal-title":"Can J Gastroenterol"},{"issue":"3","key":"10.1378\/chest.14-1925_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/ndt\/gfi305","article-title":"Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients","volume":"21","author":"P\u00f6ge","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1378\/chest.14-1925_bib44","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/hep.26886","article-title":"Creatinine- versus cystatine C-based equations in assessing the renal function of candidates for liver transplantation with cirrhosis","volume":"59","author":"De Souza","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1378\/chest.14-1925_bib45","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1378\/chest.14-1925_bib46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","article-title":"Bacterial infections, sepsis, and multiorgan failure in cirrhosis.","volume":"28","author":"Tandon","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1378\/chest.14-1925_bib47","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1378\/chest.14-1925_bib48","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective \u00df blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1378\/chest.14-1925_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1378\/chest.14-1925_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ndt\/gfr736","article-title":"Medical management of hepatorenal syndrome","volume":"27","author":"Davenport","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1378\/chest.14-1925_bib51","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1378\/chest.14-1925_bib52","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.20829","article-title":"A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis","volume":"42","author":"Fern\u00e1ndez","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1378\/chest.14-1925_bib53","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00134-013-2840-0","article-title":"Fluid resuscitation with 6 % hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy","volume":"39","author":"Gattas","year":"2013","journal-title":"Intensive Care Med"},{"issue":"20","key":"10.1378\/chest.14-1925_bib54","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1378\/chest.14-1925_bib55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis","volume":"309","author":"Zarychanski","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1378\/chest.14-1925_bib56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10620-013-2899-z","article-title":"Targeting an early and substantial increase in mean arterial pressure is critical in the management of type 1 hepatorenal syndrome: a combined retrospective and pilot study","volume":"59","author":"Maddukuri","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1378\/chest.14-1925_bib57","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"issue":"4","key":"10.1378\/chest.14-1925_bib58","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/hep.510280407","article-title":"Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites","volume":"28","author":"Angeli","year":"1998","journal-title":"Hepatology"},{"issue":"3","key":"10.1378\/chest.14-1925_bib59","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s10620-006-9312-0","article-title":"Octreotide\/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome","volume":"52","author":"Esrailian","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1378\/chest.14-1925_bib60","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/jhep.2003.50276","article-title":"Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study","volume":"38","author":"Pomier-Layrargues","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1378\/chest.14-1925_bib61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/MCG.0b013e318188947c","article-title":"Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome","volume":"43","author":"Skagen","year":"2009","journal-title":"J Clin Gastroenterol"},{"issue":"2","key":"10.1378\/chest.14-1925_bib62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1478-3231.2008.01778.x","article-title":"The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study","volume":"29","author":"Tandon","year":"2009","journal-title":"Liver Int"},{"issue":"4","key":"10.1378\/chest.14-1925_bib63","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1345\/aph.1L373","article-title":"Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications","volume":"43","author":"Karwa","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1378\/chest.14-1925_bib64","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","article-title":"Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials","volume":"25","author":"Sagi","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1378\/chest.14-1925_bib65","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"J Hepatol"},{"issue":"4","key":"10.1378\/chest.14-1925_bib66","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1378\/chest.14-1925_bib67","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1378\/chest.14-1925_bib68","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1378\/chest.14-1925_bib69","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"issue":"8","key":"10.1378\/chest.14-1925_bib70","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/liv.12179","article-title":"Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study","volume":"33","author":"Ghosh","year":"2013","journal-title":"Liver Int"},{"issue":"9","key":"10.1378\/chest.14-1925_bib71","doi-asserted-by":"crossref","first-page":"e107466","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1378\/chest.14-1925_bib72","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J Hepatol"},{"issue":"4","key":"10.1378\/chest.14-1925_bib73","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"issue":"9","key":"10.1378\/chest.14-1925_bib74","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/ndt\/gfh930","article-title":"Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study","volume":"20","author":"Kiser","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1378\/chest.14-1925_bib75","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1592\/phco.29.10.1196","article-title":"Treatment of hepatorenal syndrome","volume":"29","author":"Kiser","year":"2009","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1378\/chest.14-1925_bib76","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"9149","key":"10.1378\/chest.14-1925_bib77","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(05)74933-3","article-title":"Improvement in renal function in hepatorenal syndrome with N-acetylcysteine","volume":"353","author":"Holt","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1378\/chest.14-1925_bib78","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0168-8278(05)80042-X","article-title":"Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure","volume":"17","author":"Gin\u00e8s","year":"1993","journal-title":"J Hepatol"},{"issue":"7","key":"10.1378\/chest.14-1925_bib79","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/archinte.1975.00330070086014","article-title":"Response to dopamine hydrochloride in the hepatorenal syndrome","volume":"135","author":"Bennett","year":"1975","journal-title":"Arch Intern Med"},{"issue":"2-3","key":"10.1378\/chest.14-1925_bib80","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0168-8278(92)90182-O","article-title":"Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis","volume":"14","author":"Brenard","year":"1992","journal-title":"J Hepatol"},{"issue":"6","key":"10.1378\/chest.14-1925_bib81","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0168-8278(97)80456-4","article-title":"Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites","volume":"26","author":"Gadano","year":"1997","journal-title":"J Hepatol"},{"issue":"1","key":"10.1378\/chest.14-1925_bib82","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.21940","article-title":"Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome","volume":"47","author":"Wong","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1378\/chest.14-1925_bib83","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00000658-198810000-00012","article-title":"Manipulation of ascitic fluid pressure in cirrhotics to optimize hemodynamic and renal function","volume":"208","author":"Savino","year":"1988","journal-title":"Ann Surg"},{"issue":"1","key":"10.1378\/chest.14-1925_bib84","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00134-008-1253-y","article-title":"Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites","volume":"35","author":"Umgelter","year":"2009","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1378\/chest.14-1925_bib85","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/cc6765","article-title":"Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial","volume":"12","author":"Umgelter","year":"2008","journal-title":"Crit Care"},{"issue":"2","key":"10.1378\/chest.14-1925_bib86","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"issue":"12","key":"10.1378\/chest.14-1925_bib87","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/00042737-200212000-00013","article-title":"Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2","volume":"14","author":"Alessandria","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1378\/chest.14-1925_bib88","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/hep.20559","article-title":"The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension","volume":"41","author":"Boyer","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1378\/chest.14-1925_bib89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1378\/chest.14-1925_bib90","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-139X.2008.00539.x","article-title":"Continuous renal replacement therapies in patients with liver disease","volume":"22","author":"Davenport","year":"2009","journal-title":"Semin Dial"},{"issue":"3","key":"10.1378\/chest.14-1925_bib91","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1525-139X.2005.18315.x","article-title":"Renal replacement therapy in patients with chronic liver disease","volume":"18","author":"Howard","year":"2005","journal-title":"Semin Dial"},{"issue":"5","key":"10.1378\/chest.14-1925_bib92","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-200035988","article-title":"The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis","volume":"26","author":"Capling","year":"2004","journal-title":"Ren Fail"},{"issue":"2","key":"10.1378\/chest.14-1925_bib93","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229509026250","article-title":"Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): the role of hemodialysis","volume":"17","author":"Keller","year":"1995","journal-title":"Ren Fail"},{"issue":"5","key":"10.1378\/chest.14-1925_bib94","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1526-0968.2001.00388.x","article-title":"Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system","volume":"5","author":"Mitzner","year":"2001","journal-title":"Apher"},{"issue":"3","key":"10.1378\/chest.14-1925_bib95","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1378\/chest.14-1925_bib96","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/CCM.0b013e318211fdc4","article-title":"Critical care management of patients with end-stage liver disease","volume":"39","author":"Al-Khafaji","year":"2011","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1378\/chest.14-1925_bib97","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1378\/chest.14-1925_bib98","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1378\/chest.14-1925_bib99","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2009.04.017","article-title":"The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome","volume":"51","author":"Cazzaniga","year":"2009","journal-title":"J Hepatol"},{"issue":"7","key":"10.1378\/chest.14-1925_bib100","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1478-3231.2006.01302.x","article-title":"Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study","volume":"26","author":"Schepke","year":"2006","journal-title":"Liver Int"},{"issue":"1","key":"10.1378\/chest.14-1925_bib101","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.","volume":"40","author":"Restuccia","year":"2004","journal-title":"J Hepatol"},{"issue":"3","key":"10.1378\/chest.14-1925_bib102","first-page":"159","article-title":"Pretransplant renal dysfunction predicts poorer outcome in liver transplantation","volume":"48","author":"Lafayette","year":"1997","journal-title":"Clin Nephrol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215503528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T05:50:53Z","timestamp":1598853053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215503528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":102,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0012369215503528"],"URL":"https:\/\/doi.org\/10.1378\/chest.14-1925","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}